A transdermal review on permeation of drug formulations, modifier compounds and delivery methods

被引:13
作者
Rai, V. [1 ]
Ghosh, I. [2 ]
Bose, S. [2 ]
Silva, S. M. C. [3 ,4 ]
Chandra, P. [4 ]
Michniak-Kohn, B. [1 ,4 ]
机构
[1] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA
[2] Novartis Pharmaceut, E Hanover, NJ 07936 USA
[3] Univ Coimbra, Fac Farm, P-3000548 Coimbra, Portugal
[4] New Jersey Ctr Biomat, Piscataway, NJ 08854 USA
关键词
Percutaneous drug delivery; Formulation effect; Pig skin; Rat skin; Human skin equivalents; Permeation modifiers; Flux; Enhancers; Retardants; Biochemistry of skin; In vivo/in vitro correlation (IVIVC); Organization for Economic Co-operation and Development(OECD); RECONSTRUCTED HUMAN EPIDERMIS; CHEMICAL PENETRATION ENHANCERS; VITRO/IN-VIVO CORRELATION; HUMAN-SKIN PENETRATION; IN-VITRO; STRATUM-CORNEUM; PERMEABILITY BARRIER; PERCUTANEOUS PENETRATION; SPHINGOLIPID SYNTHESIS; GENE-EXPRESSION;
D O I
10.1016/S1773-2247(10)50011-X
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article systematically reviews the status of in vitro and in vivo percutaneous permeation of selected compounds reported in the literature and attempts to relate these permeation data to formulations and biochemical changes occurring in human skin, animal skins and skin equivalents. A substantial portion of the article is dedicated in reviewing the status of commercially available drugs and their delivery methods. Information on permeation modifier compounds and in vivo/in vitro (IVIVC) correlations is also provided in order to obtain a complete picture of the research status in the dermatopharmaceutical field.
引用
收藏
页码:75 / 87
页数:13
相关论文
共 123 条
[1]   Transdermal delivery of nicardipine: An approach to in vitro permeation enhancement [J].
Aboofazeli, R ;
Zia, H ;
Needham, TE .
DRUG DELIVERY, 2002, 9 (04) :239-247
[2]   Chemical penetration enhancers: a patent review [J].
Ahad, Abdul ;
Aqil, Mohammed ;
Kohli, Kanchan ;
Chaudhary, Hema ;
Sultana, Yasmin ;
Mujeeb, Mohammed ;
Talegaonkar, Sushama .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2009, 19 (07) :969-988
[3]   Cellular responses to disruption of the permeability barrier in a three-dimensional organotypic epidermal model [J].
Ajani, Gati ;
Sato, Nobuyuki ;
Mack, Judith A. ;
Maytin, Edward V. .
EXPERIMENTAL CELL RESEARCH, 2007, 313 (14) :3005-3015
[4]   Variability in human skin permeability in vitro:: Comparing penetrants with different physicochemical properties [J].
Akomeah, Franklin K. ;
Martin, Gary P. ;
Brown, Marc B. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (04) :824-834
[5]   Status of terpenes as skin penetration enhancers [J].
Aqil, Mohammed ;
Ahad, Abdul ;
Sultana, Vasmin ;
Ali, Asgar .
DRUG DISCOVERY TODAY, 2007, 12 (23-24) :1061-1067
[6]   Micro-scale devices for transdermal drug delivery [J].
Arora, Anubhav ;
Prausnitz, Mark R. ;
Mitragotri, Samir .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2008, 364 (02) :227-236
[7]   Evaluation of a human bio-engineered skin equivalent for drug permeation studies [J].
Asbill, C ;
Kim, N ;
El-Kattan, A ;
Creek, K ;
Wertz, P ;
Michniak, B .
PHARMACEUTICAL RESEARCH, 2000, 17 (09) :1092-1097
[8]   Improved barrier function observed in cultured skin substitutes developed under anchored conditions [J].
Barai, Namrata D. ;
Boyce, Steven T. ;
Hoath, Steven B. ;
Visscher, Marty O. ;
Kasting, Gerald B. .
SKIN RESEARCH AND TECHNOLOGY, 2008, 14 (04) :418-424
[9]   Novel mechanisms and devices to enable successful transdermal drug delivery [J].
Barry, BW .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 14 (02) :101-114
[10]   Breaching the skin's barrier to drugs [J].
Barry, BW .
NATURE BIOTECHNOLOGY, 2004, 22 (02) :165-167